New drug DD-S052P takes first step: safety check in healthy volunteers
NCT ID NCT07347223
First seen Jan 17, 2026 · Last updated May 21, 2026 · Updated 17 times
Summary
This early-stage study tested a new drug, DD-S052P, in 64 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo by IV, in single or multiple doses. The goal was to check for side effects and measure drug levels in the blood, helping decide if further testing is possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
HLB Science
Seoul, Seoul, 05836, South Korea
Conditions
Explore the condition pages connected to this study.